Delivery Order SPE2DB25D3404-SPE2DB26FULVM
Award Date 10/27/25
Potential Completion Date 10/28/25
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $30,345.64 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of October 23, 2025. This is a firm fixed-price, non-set-aside award issued on October 22, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $10,388.67 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens. This competitive, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $59,501.28 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pens. This competitively awarded, firm fixed price delivery order was issued on October 22, 2025, with an ultimate completion date of October 23, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. ENBREL is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis, psoriasis, and...
- The Defense Logistics Agency awarded a delivery order valued at $10,357.26 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 20, 2025. This non-set-aside, firm fixed price delivery order was issued under a competitive procurement process and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis...
- The Defense Logistics Agency awarded a delivery order valued at $33,637.70 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens on September 9, 2025, with a completion date of September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication used to treat rheumatoid...
- The Defense Logistics Agency awarded a $25,050.69 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with a completion date of June 23, 2025. This non-competitive delivery order represents a firm fixed price purchase executed on June 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL (etanercept) is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other...
- The Defense Logistics Agency awarded a $25,638.42 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $14,387.79 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pens, with an ultimate completion date of August 28, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $23,960.38 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pens, with an ultimate completion date of August 21, 2025. This non-competitive, firm fixed-price delivery order was issued on August 20, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,211.70 for ENBREL 50 mg/ml SureClick auto-injector pens on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...